IPO Profile: Coherus Biosciences Inc

Biotech company had a market cap of about $448 million at the end of November

1 December 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.